Humanin vs NAD+ Precursors
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: HN, HNG (S14G-humanin)
A mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Also: NMN, NR
While not peptides, NAD+ precursors are frequently discussed alongside peptides in longevity circles. They boost cellular NAD+ levels, supporting energy metabolism and sirtuin activity.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- NAD+ Precursors has stronger research evidence (Human Trials) compared to Humanin (Animal Studies).
Detailed Comparison
| Attribute | Humanin | NAD+ Precursors |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Humanin acts through multiple pathways including STAT3 signaling, binding to IGFBP-3, and activating the FPRL1 receptor. It protects neurons from apoptosis, improves insulin sensitivity, and has anti-inflammatory effects. | NMN and NR are converted to NAD+ in cells. NAD+ is essential for mitochondrial function, DNA repair, and sirtuin enzyme activity. Sirtuins regulate metabolism, stress response, and longevity pathways. NAD+ levels decline with age. |
| Common Dosing | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) | Limited community data available See research protocols |
| Administration | Injection (route varies) | Oral (capsules, sublingual) |
| Typical Duration | Variable | Ongoing supplementation |
| Best Time to Take | Morning | Morning or before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Research shows protection against amyloid-beta toxicity in Alzheimer's models. Studies demonstrate improved insulin sensitivity, reduced atherosclerosis in animal models, and potential anti-aging effects. Human studies are limited. | Animal studies show improved metabolic function, enhanced exercise capacity, and extended healthspan. Human trials demonstrate safety and NAD+ elevation. Long-term benefits in humans still being established. David Sinclair's research popularized the field. |
Frequently Asked Questions: Humanin vs NAD+ Precursors
What is the difference between Humanin and NAD+ Precursors?
Humanin is a anti-aging peptide that a mitochondria-derived peptide discovered for its neuroprotective effects against alzheimer's-related toxicity. being studied for aging and metabolic benefits. NAD+ Precursors is a anti-aging peptide that while not peptides, nad+ precursors are frequently discussed alongside peptides in longevity circles. they boost cellular nad+ levels, supporting energy metabolism and sirtuin activity. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Humanin or NAD+ Precursors?
Neither is universally "better" - the choice depends on your specific goals. Humanin is typically used for anti-aging purposes, while NAD+ Precursors is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Humanin and NAD+ Precursors be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Humanin and NAD+ Precursors together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of Humanin and NAD+ Precursors is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.